Table 3.
Antimicrobial | Isolate | ||||||||
---|---|---|---|---|---|---|---|---|---|
Class | Agent | 10040013 | 10420013 | 10500013 | 10600013 | 10780027 | 10830027 | 10940027 | 10990027 |
Aminocyclitol | SPT | aadA1 | aadA1, aadA2 | aadA1, aadA2 | aadA1 | aadA2 | aadA2 | aadA1 | aadA5 |
Aminoglycoside | GEN | aac(3)-IId | aac(3)-IId | ||||||
NEO | aph(3')-Ia | aph(3')-Ia | aph(3')-Ia | aph(3')-Ia | |||||
STR |
aadA1 strA/strB |
aadA1, aadA2 |
aadA1, aadA2 strA/strB |
aadA1 strA/strB |
aadA2 strA/strB |
aadA2 strA/strB |
aadA1 strA/strB |
aadA5 strA/strB |
|
Aminopenicillin | AMP | blaCMY−2, blaTEM−1B | blaCARB−2 | ampC* | blaCMY−2 blaTEM−1B | blaCMY−2 blaTEM−1B | ampC* | ampC* | blaTEM−1B |
Amino/β-lac inh‡ | AMC | blaCMY−2 | ampC* | blaCMY−2 | blaCMY−2 | ampC* | ampC* | ||
Cephamycin | FOX | blaCMY−2 | ampC* | blaCMY−2 | blaCMY−2 | ampC* | ampC* | ||
Cephalosporin | TIO | blaCMY−2 | ampC* | blaCMY−2 | blaCMY−2 | ampC* | ampC* | ||
CRO | blaCMY−2 | ampC* | blaCMY−2 | blaCMY−2 | ampC* | ampC* | |||
Folate pathway | FIS | sul2 | sul3 | sul1, sul2 | sul2 | sul, sul2 | sul, sul2 | sul2 | sul, sul2 |
antagonist | SXT | dfrA1 | dfrA16 | dfrA23 | dfrA1 | dfrA12 | dfrA23 | dfrA1 | dfrA17 |
Macrolide | AZM | mph(A) | |||||||
Phenicol | CHL | floR | cmlA1† | floR | floR | floR | floR | floR | floR |
Quinolone | DAN | gyrA† | gyrA† | ||||||
ENR | gyrA† | gyrA† | |||||||
NAL | gyrA† | gyrA† | |||||||
Tetracycline | TET | tet(B) | tet(A) | tet(A) | tet(B) | tet(A), tet(B) | tet(A), tet(B) | tet(A) | tet(A) |
Phenotypic resistance is represented by dark and light gray cells for intermediate and resistant isolates, respectively. White cells are for susceptible isolates. Resistance genes indicated in cells denote their presence for a particular isolate.
Promoter mutation in ampC−42 C -> T;
Mutation in gyrA S83L;
Penicillin +β-lactamase inhibitor.
AMC, amoxicillin-clavulanic acid; AMP, ampicillin; AZM, azithromycin; CHL, chloramphenicol; CRO, ceftriaxone; DAN, danofloxacin; ENR, enrofloxacin; FIS, sulfisoxazole; FOX, cefoxitin; GEN, gentamicin; NAL, nalidixic acid; NEO, neomycin; SPT, spectinomycin; STR, streptomycin; SXT, trimethoprim-sulfamethoxazole; TET, tetracycline; TIO, ceftiofur.